WHO Grade 3 Glioma Active Not Recruiting Phase 2 Trials for Olaparib (DB09074)

Also known as: WHO Grade III Gliomas / Grade III Glioma / WHO Grade III Glioma

IndicationStatusPhase
DBCOND0146359 (WHO Grade 3 Glioma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03212274Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsTreatment